Category: News from the industry

The CQDM has joined forces with the RSRI to send a strong message in the face of economic and commercial uncertainties: it is more urgent than ever to take action!

The CQDM is proud to join forces with the 8 other RSRI (Sectoral Industrial Research Groups) to deliver a strong message with one unified voice:Innovation is the key to ensuring the resilience and competitiveness of our Quebec businesses.The collaboration between research and industry is essential to transform ideas into concrete solutions. In a context where…

New funding opportunity for RNA therapies!

Ouverture de l’appel à solutions AReNA est heureux d’annoncer le lancement du premier appel à solutions de la CELLULE. Cette nouvelle approche d’accompagnement et de financement des innovations permettra d’accélérer le développement de technologies hautement prometteuses ayant le potentiel de résoudre certaines problématiques industrielles d’importance limitant actuellement le développement et l’utilisation des thérapies ARN. Les…

CQDM announces the creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies

Montréal, le 11 juin 2024 – Le CQDM est fier d’annoncer la création du Réseau de développement et de production de thérapies ARN qui offrira des services de biofabrication en thérapies ARN aux chercheurs académiques et industriels. Mené par l’Institut de recherches cliniques de Montréal (IRCM), l’Université McGill et l’Université Sherbrooke, ce Réseau s’inscrit parmi…

CQDM announces a new initiative to stimulate innovation and entrepreneurship in the RNA therapy sector in Quebec

Cette nouvelle initiative sera mise en œuvre avec l’appui et l’expertise de Axelys Montréal, le 6 juin 2024 – Le CQDM est heureux d’annoncer le lancement d’une nouvelle initiative ambitieuse visant à stimuler l’innovation et l’entrepreneuriat dans la filière de l’ARN thérapeutique au Québec. Menée par Axelys, en collaboration avec plusieurs partenaires, cette initiative s’inscrit…

Québec Launches AReNA to Become a Global Leader in RNA Therapies

San Diego, California – June 3rd, 2024 – CQDM, in collaboration with Axelys, Montréal InVivo and RNA Québec is proud to introduce AReNA, the new Québec’s RNA Hub. Unveiled at the BIO conference in San Diego, in the presence of the Minister for the Economy, the Minister responsible for the Fight Against Racism, and the…

2024 OBIO Investment Summit

CQDM. We share.Canadian health science companies are invited to submit an expression of interest to pitch in person to global investors at the 2024 OBIO® Investment Summit (OIS) in Toronto on February 14–16, 2024.Selected Canadian health science companies seeking their next raise and demonstrating high growth potential and readiness for investment will pitch virtually to…

$50 million to support biotech companies

$50 million to support biotech companies. In order to ensure the continuity of the financing chain for the life sciences sector, the government of Quebec announces the renewal of BioMed Propulsion. This will be allocated an envelope of $50 million to support biotechnology and medical technology companies which have already reached the early stages of their…

AI and drug development

AI and drug development.An interesting conference discussing artificial intelligence and drug development. Come hear Yoshua Bengio discuss AI advances in the field at the next adMare BioInnovations ‘Global Leaders’ series event.-Thursday, October 5, at noon (EST)-Online webinar-RSVP: https://www.admarebio.com/en/events-details/detail/admare-global-leader-series-featuring-yoshua-bengio/45424

Congratulations Université Laval

Congratulations Université Laval. A large-scale international collaborative study lead by Professor Jacques Simard from Université Laval and Professor Douglas Easton at the University of Cambridge, UK, has identified new genes associated with breast cancer that could eventually be included in tests to identify women at increased risk. The study found evidence for at least four…